Recent research published by THE SAGE GROUP examined the number of PAD patients undergoing endovascular procedures by site of service; hospital inpatient, hospital outpatient (HOPD) and office-based ...

Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Sage To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Sage ...

The global postpartum depression management market is set to grow steadily over the next decade, with a projected compound ...

On Friday, SAGE Therapeutics Inc (SAGE) stock saw a modest uptick, ending the day at $6.59 which represents a slight increase of $0.22 or 3.45% from the prior close of $6.37. The stock opened at $6.33 ...

Sage Therapeutics (NASDAQ:SAGE – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Raymond James in a note issued to investors on Thursday, MarketBeat.com reports.

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

On Wednesday, SAGE Therapeutics Inc (SAGE) stock saw a modest uptick, ending the day at $6.49 which represents a slight increase of $0.06 or 0.93% from the prior close of $6.43. The stock opened at $6 ...

Former Columbia University psychiatrist Bret Rutherford, MD, committed research misconduct by "falsely reporting that all ...

SAGE Therapeutics (SAGE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Douglas ...

TD Cowen analyst Ritu Baral maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) today and set a price target of ...

Biogen's stock has had a rough time over the past few months. In late July, not only did European regulators reject Biogen's treatment for Alzheimer's disease, the company and partner Sage ...

Here are the five things you need to know in local business news to start your busy Wednesday, including Amazon's empty office building, Jack's Abby's new buy, shopping plaza sales and what you need ...